Gastromep

Omeprazole Delayed-Release (20mg)

Standard PackHigh-density polyethylene (HDPE) bottles of 30 delayed-release capsules with child-resistant caps and silica gel desiccant

Facility StatusWHO-GMP Approved

Technical Specifications

Chemical ClassSubstituted benzimidazole (Proton Pump Inhibitor)

RouteOral (Capsule)

StorageStore in a tightly closed container at 15°C to 30°C (59°F to 86°F), protected from light and moisture.

Regulatory ClassOver-the-Counter / Prescription (Rx/OTC)

Gastrointestinal

Gastromep

Active Ingredient: Omeprazole Delayed-Release (20mg)

Product Overview

Gastromep is a delayed-release formulation of Omeprazole, an antisecretory compound. It is a specific inhibitor of the gastric H+/K+-ATPase enzyme system (the proton pump) at the secretory surface of the gastric parietal cell. By blocking the final step of acid production, it effectively raises gastric pH and promotes mucosal healing in acid-related disorders.

Composition & Ingredients

Omeprazole (20mg) in enteric-coated granules - Active Ingredient

Mannitol USP

Sodium Lauryl Sulfate NF

Disodium Hydrogen Phosphate

Calcium Carbonate

Hypromellose

Methacrylic Acid Copolymer Dispersion

Administration & Dosage

Recommended dose is 20mg once daily, taken 30 to 60 minutes before breakfast. For severe erosive esophagitis, the dose may be increased to 40mg daily for 4 to 8 weeks as determined by a physician.

Packaging Specifications

High-density polyethylene (HDPE) bottles of 30 delayed-release capsules with child-resistant caps and silica gel desiccant.

Critical Safety Information

May mask symptoms of gastric malignancy. Diagnostic evaluation should be performed prior to treatment in symptomatic adults.
Long-term daily treatment (e.g., >3 years) may lead to malabsorption of Vitamin B-12).
Concomitant use of Omeprazole with Clopidogrel should be avoided due to competitive CYP2C19 metabolism.

Consult a physician prior to prescribing or administering this agent.